Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Trial of STI571 (NSC 716051) in Patients With Recurrent Meningioma

NCT00045734 is registered in ClinicalTrials.gov with National Cancer Institute (NCI) as lead sponsor.

NCT NCT00045734
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00045734 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Trial of STI571 (NSC 716051) in Patients With Recurrent Meningioma
Lead sponsor
National Cancer Institute (NCI)
Phase
Phase 2
Overall status
Completed
Start date
February 28, 2003
Completion date
December 31, 2009
Enrollment
23 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

adult grade i meningioma, adult grade ii meningioma, adult grade iii meningioma, adult meningeal hemangiopericytoma, adult meningioma, recurrent adult brain tumor